VYNE Therapeutics Inc (VYNE) EPS is poised to hit -0.30 next quarter: How Investors Can Make It Count the Most?
Witnessing the stock’s movement on the chart, on Wednesday, VYNE Therapeutics Inc (NASDAQ: VYNE) had a quiet start as it plunged -8.41% to $3.92, before